Neurexis Therapeutics Employee Directory
Biotechnology ResearchColorado, United States2-10 Employees
Neurexis Therapeutics is a biotechnology research company focused on developing neuroprotective interventions, specifically an optimized peptide demonstrated to be effective and safe in animal models of global cerebral ischemia. Based in Aurora, Colorado, the firm operates within the biotechnology research sector and targets applications that address neurological injury, aiming to advance clinical options for conditions arising from cerebral ischemia. The organization appears to maintain a small operations footprint, with activities centered on preclinical or translational research in neuroprotection, supported by a history of NIH-funded grant programs. A notable recent development is the company’s recognition by the NIH in pursuing later-stage development under the SBIR program, reflecting ongoing work toward clinical advancement in its therapeutic area.